Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Cancer

Figure 4

From: Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis

Figure 4

Cancer-specific survival of patients classified based on haplotype in the LD block 3 in subgroups dichotomized by Gleason score or pretreatment ALP level. Patients with C-T haplotype showed significantly worse survival than those having no C-T haplotype (P = 0.0002) in patients with Gleason score of 9–10 (A), while there was no significant difference (P = 0.365) in patients with Gleason score less than 9 (B). In a subgroup analysis by pretreatment ALP level, patients with C-T haplotype showed significantly shorter survival than those with no C-T haplotype in either subgroup of patients with lower (< 350 IU/L) or higher (≥ 350 IU/L) ALP (P = 0.010 or 0.009, respectively) (C and D).

Back to article page